Compare ACAD & ALH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACAD | ALH |
|---|---|---|
| Founded | 1993 | 1908 |
| Country | United States | United States |
| Employees | N/A | 3973 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.9B |
| IPO Year | 2000 | N/A |
| Metric | ACAD | ALH |
|---|---|---|
| Price | $20.83 | $23.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 22 | 8 |
| Target Price | $30.55 | ★ $30.88 |
| AVG Volume (30 Days) | ★ 1.5M | 589.9K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 69.12 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $726,437,000.00 | N/A |
| Revenue This Year | $18.80 | $7.42 |
| Revenue Next Year | $11.70 | $5.88 |
| P/E Ratio | $1,029.50 | ★ $35.43 |
| Revenue Growth | ★ 40.45 | N/A |
| 52 Week Low | $19.69 | $18.64 |
| 52 Week High | $28.35 | $27.48 |
| Indicator | ACAD | ALH |
|---|---|---|
| Relative Strength Index (RSI) | 41.42 | 44.63 |
| Support Level | $20.06 | $23.75 |
| Resistance Level | $22.64 | $25.11 |
| Average True Range (ATR) | 0.79 | 0.87 |
| MACD | -0.17 | -0.33 |
| Stochastic Oscillator | 18.95 | 23.39 |
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare diseases. Its neurological disease is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. (FDA) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.
Alliance Laundry Holdings Inc is a designer and manufacturer of commercial laundry systems, serving diverse international markets. The company offers premium, durable laundry equipment under brands like Speed Queen, UniMac, Huebsch, Primus, IPSO, and others. It serves commercial laundry needs across healthcare, hotels, laundromats, and residential markets. Revenue is generated through the sale of commercial-grade laundry systems and service parts across two geographic segments, North America and International, and into the three end markets of OPL, Vended, and Commercial In-Home.